High-efficiency engineering of cell membrane nanovesicles with intrinsic homotypic targeting for precision cancer drug delivery.

Cell membrane-derived nanovesicles (NVs; CM-NVs) have emerged as a promising next-generation platform for targeted drug delivery in cancer therapy, owing to their intrinsic biocompatibility and ability to present native surface proteins. These featur…

Preview only. Read the full abstract at the source